Revisiting T-cell adhesion molecules as potential targets for cancer immunotherapy: CD226 and CD2
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Researchers are exploring t-cell adhesion molecules as potential targets for cancer immunotherapy, with a focus on cd226 and cd2. This approach may offer new possibilities for treating cancer. The molecules cd226 and cd2 are being specifically examined for their potential role in immunotherapy.